Clinical–Immunological Phenomapping in Recurrent Pericarditis: Disentangling Biological Traits, Inflammatory State and Treatment Exposure
- 9 November 2026
- journal article
- research article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 56 (11) , e70284
Abstract
Background: Phenotype‐oriented management is increasingly advocated in recurrent pericarditis (RP), but it remains unclear whether clinically recognizable phenotypes reflect underlying disease biology or are shaped by current inflammation and treatment exposure. We used multidimensional phenomapping to investigate this heterogeneity. Methods: We analysed 101 patients with idiopathic RP from the multicenter PERIPLO cohort. Factor analysis of mixed data followed by hierarchical clustering defined the index solution. Robustness was assessed across alternative specifications and models excluding treatment, inflammatory state or the IL‐1Ra axis. Results: Three clinical–immunological patterns emerged: a predominantly remission‐state, anakinra‐treated group; a predominantly remission‐state group largely managed without IL‐1 blockade; and an active inflammatory group enriched for anti‐IL‐1Ra autoantibodies and characterized by markedly reduced measured IL‐1Ra. The two antibody‐negative groups were extensively reorganized after treatment variables were removed, whereas exclusion of the IL‐1Ra axis nearly abolished agreement with the original partition. In contrast, anti‐IL‐1Ra positivity remained consistently associated with active inflammation and very low measured IL‐1Ra. Conclusions: In this cohort, the phenotypic heterogeneity of RP was better represented as a clinical–immunological spectrum shaped by inflammatory state and treatment exposure than as discrete, stable endotypes. The anti‐IL‐1Ra‐associated inflammatory signature was the most internally consistent biological signal. These exploratory findings require external validation, and longitudinal multidimensional phenomapping should test whether this signature can inform patient management.Keywords
This publication has 22 references indexed in Scilit:
- IL-1 Receptor Antagonist Antibodies in Idiopathic Recurrent PericarditisJAMA Network Open, 2025
- Prognostic role of genetic variants in recurrent pericarditisInternational Journal of Cardiology, 2025
- Diagnosis, Risk Stratification, and Treatment of PericarditisJAMA, 2024
- Recurrent Pericarditis and Paradigm Shift in Cardiovascular Imaging and Targeted TherapeuticsJACC: Advances, 2024
- Variants at the Interleukin 1 Gene Locus and PericarditisJAMA Cardiology, 2024
- Acute pericarditis with pleuropulmonary involvement, fever and elevated C-reactive protein: A systemic autoinflammatory disease? A cohort studyEuropean Journal of Internal Medicine, 2023
- Predictors of relapse, death or heart transplantation in myocarditis before the introduction of immunosuppression: negative prognostic impact of female gender, fulminant onset, lower ejection fraction and serum autoantibodiesEuropean Journal of Heart Failure, 2022
- The Role of NLRP3 Inflammasome in PericarditisJACC: Basic To Translational Science, 2021
- Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid DependenceJAMA, 2016
- Complicated PericarditisJACC, 2016